Q BioMed Inc.
Q BioMed Inc. QBIO Peers
See (QBIO) competitors and their performances in Stock Market.
Peer Comparison Table: Biotechnology Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| QBIO | $0.00 | N/A | 14510.00 | N/A | -$0.02 | N/A |
| NONOF | $63.75 | -2.75% | 282.98B | 18.11 | $3.52 | +2.55% |
| CSLLY | $77.53 | +1.15% | 150.16B | 28.40 | $2.73 | +1.71% |
| CMXHF | $161.19 | +10.03% | 78.05B | 29.58 | $5.45 | +1.72% |
| ARGNF | $562.00 | N/A | 34.32B | 34.25 | $16.41 | N/A |
| UCBJY | $88.75 | +1.98% | 33.73B | 29.00 | $3.06 | +0.61% |
| UCBJF | $168.65 | -1.23% | 32.05B | 27.51 | $6.13 | +0.73% |
| ODTC | $22,005.00 | +29.44% | 24.14B | -0.08 | -$268,995.00 | N/A |
| WXXWY | $6.00 | -1.32% | 12.19B | 27.27 | $0.22 | N/A |
| WXIBF | $3.00 | N/A | 12.19B | 27.27 | $0.11 | N/A |
Stock Comparison
QBIO vs NONOF Comparison
QBIO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QBIO stands at 14510.00. In comparison, NONOF has a market cap of 282.98B. Regarding current trading prices, QBIO is priced at $0.00, while NONOF trades at $63.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QBIO currently has a P/E ratio of N/A, whereas NONOF's P/E ratio is 18.11. In terms of profitability, QBIO's ROE is +0.44%, compared to NONOF's ROE of +0.81%. Regarding short-term risk, QBIO is less volatile compared to NONOF. This indicates potentially lower risk in terms of short-term price fluctuations for QBIO.
QBIO vs CSLLY Comparison
QBIO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QBIO stands at 14510.00. In comparison, CSLLY has a market cap of 150.16B. Regarding current trading prices, QBIO is priced at $0.00, while CSLLY trades at $77.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QBIO currently has a P/E ratio of N/A, whereas CSLLY's P/E ratio is 28.40. In terms of profitability, QBIO's ROE is +0.44%, compared to CSLLY's ROE of +0.15%. Regarding short-term risk, QBIO is less volatile compared to CSLLY. This indicates potentially lower risk in terms of short-term price fluctuations for QBIO.
QBIO vs CMXHF Comparison
QBIO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QBIO stands at 14510.00. In comparison, CMXHF has a market cap of 78.05B. Regarding current trading prices, QBIO is priced at $0.00, while CMXHF trades at $161.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QBIO currently has a P/E ratio of N/A, whereas CMXHF's P/E ratio is 29.58. In terms of profitability, QBIO's ROE is +0.44%, compared to CMXHF's ROE of +0.15%. Regarding short-term risk, QBIO and CMXHF have similar daily volatility (0.00).
QBIO vs ARGNF Comparison
QBIO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QBIO stands at 14510.00. In comparison, ARGNF has a market cap of 34.32B. Regarding current trading prices, QBIO is priced at $0.00, while ARGNF trades at $562.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QBIO currently has a P/E ratio of N/A, whereas ARGNF's P/E ratio is 34.25. In terms of profitability, QBIO's ROE is +0.44%, compared to ARGNF's ROE of +0.16%. Regarding short-term risk, QBIO and ARGNF have similar daily volatility (0.00).
QBIO vs UCBJY Comparison
QBIO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QBIO stands at 14510.00. In comparison, UCBJY has a market cap of 33.73B. Regarding current trading prices, QBIO is priced at $0.00, while UCBJY trades at $88.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QBIO currently has a P/E ratio of N/A, whereas UCBJY's P/E ratio is 29.00. In terms of profitability, QBIO's ROE is +0.44%, compared to UCBJY's ROE of +0.03%. Regarding short-term risk, QBIO is less volatile compared to UCBJY. This indicates potentially lower risk in terms of short-term price fluctuations for QBIO.
QBIO vs UCBJF Comparison
QBIO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QBIO stands at 14510.00. In comparison, UCBJF has a market cap of 32.05B. Regarding current trading prices, QBIO is priced at $0.00, while UCBJF trades at $168.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QBIO currently has a P/E ratio of N/A, whereas UCBJF's P/E ratio is 27.51. In terms of profitability, QBIO's ROE is +0.44%, compared to UCBJF's ROE of +0.03%. Regarding short-term risk, QBIO and UCBJF have similar daily volatility (0.00).
QBIO vs ODTC Comparison
QBIO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QBIO stands at 14510.00. In comparison, ODTC has a market cap of 24.14B. Regarding current trading prices, QBIO is priced at $0.00, while ODTC trades at $22,005.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QBIO currently has a P/E ratio of N/A, whereas ODTC's P/E ratio is -0.08. In terms of profitability, QBIO's ROE is +0.44%, compared to ODTC's ROE of +0.07%. Regarding short-term risk, QBIO and ODTC have similar daily volatility (0.00).
QBIO vs WXXWY Comparison
QBIO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QBIO stands at 14510.00. In comparison, WXXWY has a market cap of 12.19B. Regarding current trading prices, QBIO is priced at $0.00, while WXXWY trades at $6.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QBIO currently has a P/E ratio of N/A, whereas WXXWY's P/E ratio is 27.27. In terms of profitability, QBIO's ROE is +0.44%, compared to WXXWY's ROE of +0.06%. Regarding short-term risk, QBIO is less volatile compared to WXXWY. This indicates potentially lower risk in terms of short-term price fluctuations for QBIO.
QBIO vs WXIBF Comparison
QBIO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QBIO stands at 14510.00. In comparison, WXIBF has a market cap of 12.19B. Regarding current trading prices, QBIO is priced at $0.00, while WXIBF trades at $3.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QBIO currently has a P/E ratio of N/A, whereas WXIBF's P/E ratio is 27.27. In terms of profitability, QBIO's ROE is +0.44%, compared to WXIBF's ROE of +0.06%. Regarding short-term risk, QBIO and WXIBF have similar daily volatility (0.00).
QBIO vs GNMSF Comparison
QBIO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QBIO stands at 14510.00. In comparison, GNMSF has a market cap of 11.61B. Regarding current trading prices, QBIO is priced at $0.00, while GNMSF trades at $188.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QBIO currently has a P/E ratio of N/A, whereas GNMSF's P/E ratio is 11.07. In terms of profitability, QBIO's ROE is +0.44%, compared to GNMSF's ROE of +0.26%. Regarding short-term risk, QBIO is less volatile compared to GNMSF. This indicates potentially lower risk in terms of short-term price fluctuations for QBIO.
QBIO vs IVBXF Comparison
QBIO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QBIO stands at 14510.00. In comparison, IVBXF has a market cap of 9.80B. Regarding current trading prices, QBIO is priced at $0.00, while IVBXF trades at $5.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QBIO currently has a P/E ratio of N/A, whereas IVBXF's P/E ratio is -594.00. In terms of profitability, QBIO's ROE is +0.44%, compared to IVBXF's ROE of -0.01%. Regarding short-term risk, QBIO is less volatile compared to IVBXF. This indicates potentially lower risk in terms of short-term price fluctuations for QBIO.
QBIO vs SBMFF Comparison
QBIO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QBIO stands at 14510.00. In comparison, SBMFF has a market cap of 8.86B. Regarding current trading prices, QBIO is priced at $0.00, while SBMFF trades at $0.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QBIO currently has a P/E ratio of N/A, whereas SBMFF's P/E ratio is 49.50. In terms of profitability, QBIO's ROE is +0.44%, compared to SBMFF's ROE of +0.11%. Regarding short-term risk, QBIO is less volatile compared to SBMFF. This indicates potentially lower risk in terms of short-term price fluctuations for QBIO.
QBIO vs SBHMY Comparison
QBIO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QBIO stands at 14510.00. In comparison, SBHMY has a market cap of 8.48B. Regarding current trading prices, QBIO is priced at $0.00, while SBHMY trades at $9.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QBIO currently has a P/E ratio of N/A, whereas SBHMY's P/E ratio is 32.69. In terms of profitability, QBIO's ROE is +0.44%, compared to SBHMY's ROE of +0.11%. Regarding short-term risk, QBIO is less volatile compared to SBHMY. This indicates potentially lower risk in terms of short-term price fluctuations for QBIO.
QBIO vs TLPPF Comparison
QBIO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QBIO stands at 14510.00. In comparison, TLPPF has a market cap of 5.64B. Regarding current trading prices, QBIO is priced at $0.00, while TLPPF trades at $16.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QBIO currently has a P/E ratio of N/A, whereas TLPPF's P/E ratio is 185.56. In terms of profitability, QBIO's ROE is +0.44%, compared to TLPPF's ROE of +0.14%. Regarding short-term risk, QBIO is less volatile compared to TLPPF. This indicates potentially lower risk in terms of short-term price fluctuations for QBIO.
QBIO vs ABCZF Comparison
QBIO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QBIO stands at 14510.00. In comparison, ABCZF has a market cap of 5.12B. Regarding current trading prices, QBIO is priced at $0.00, while ABCZF trades at $22.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QBIO currently has a P/E ratio of N/A, whereas ABCZF's P/E ratio is 2225.00. In terms of profitability, QBIO's ROE is +0.44%, compared to ABCZF's ROE of -0.01%. Regarding short-term risk, QBIO and ABCZF have similar daily volatility (0.00).
QBIO vs INCPF Comparison
QBIO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QBIO stands at 14510.00. In comparison, INCPF has a market cap of 4.88B. Regarding current trading prices, QBIO is priced at $0.00, while INCPF trades at $3.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QBIO currently has a P/E ratio of N/A, whereas INCPF's P/E ratio is -108.67. In terms of profitability, QBIO's ROE is +0.44%, compared to INCPF's ROE of -0.05%. Regarding short-term risk, QBIO and INCPF have similar daily volatility (0.00).
QBIO vs AKBLF Comparison
QBIO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QBIO stands at 14510.00. In comparison, AKBLF has a market cap of 4.75B. Regarding current trading prices, QBIO is priced at $0.00, while AKBLF trades at $21.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QBIO currently has a P/E ratio of N/A, whereas AKBLF's P/E ratio is 33.89. In terms of profitability, QBIO's ROE is +0.44%, compared to AKBLF's ROE of +0.18%. Regarding short-term risk, QBIO is less volatile compared to AKBLF. This indicates potentially lower risk in terms of short-term price fluctuations for QBIO.
QBIO vs LABFF Comparison
QBIO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QBIO stands at 14510.00. In comparison, LABFF has a market cap of 4.63B. Regarding current trading prices, QBIO is priced at $0.00, while LABFF trades at $90.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QBIO currently has a P/E ratio of N/A, whereas LABFF's P/E ratio is 28.95. In terms of profitability, QBIO's ROE is +0.44%, compared to LABFF's ROE of +0.39%. Regarding short-term risk, QBIO and LABFF have similar daily volatility (0.00).
QBIO vs ZLDPF Comparison
QBIO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QBIO stands at 14510.00. In comparison, ZLDPF has a market cap of 4.40B. Regarding current trading prices, QBIO is priced at $0.00, while ZLDPF trades at $62.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QBIO currently has a P/E ratio of N/A, whereas ZLDPF's P/E ratio is -24.20. In terms of profitability, QBIO's ROE is +0.44%, compared to ZLDPF's ROE of -0.13%. Regarding short-term risk, QBIO and ZLDPF have similar daily volatility (0.00).
QBIO vs CAMRF Comparison
QBIO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QBIO stands at 14510.00. In comparison, CAMRF has a market cap of 3.82B. Regarding current trading prices, QBIO is priced at $0.00, while CAMRF trades at $65.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QBIO currently has a P/E ratio of N/A, whereas CAMRF's P/E ratio is 88.04. In terms of profitability, QBIO's ROE is +0.44%, compared to CAMRF's ROE of +0.14%. Regarding short-term risk, QBIO is less volatile compared to CAMRF. This indicates potentially lower risk in terms of short-term price fluctuations for QBIO.
QBIO vs SHJBF Comparison
QBIO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QBIO stands at 14510.00. In comparison, SHJBF has a market cap of 3.72B. Regarding current trading prices, QBIO is priced at $0.00, while SHJBF trades at $1.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QBIO currently has a P/E ratio of N/A, whereas SHJBF's P/E ratio is -7.30. In terms of profitability, QBIO's ROE is +0.44%, compared to SHJBF's ROE of -0.27%. Regarding short-term risk, QBIO and SHJBF have similar daily volatility (0.00).
QBIO vs REGMF Comparison
QBIO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QBIO stands at 14510.00. In comparison, REGMF has a market cap of 3.28B. Regarding current trading prices, QBIO is priced at $0.00, while REGMF trades at $5.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QBIO currently has a P/E ratio of N/A, whereas REGMF's P/E ratio is -13.32. In terms of profitability, QBIO's ROE is +0.44%, compared to REGMF's ROE of -0.48%. Regarding short-term risk, QBIO is less volatile compared to REGMF. This indicates potentially lower risk in terms of short-term price fluctuations for QBIO.
QBIO vs GNNSF Comparison
QBIO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QBIO stands at 14510.00. In comparison, GNNSF has a market cap of 2.90B. Regarding current trading prices, QBIO is priced at $0.00, while GNNSF trades at $1.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QBIO currently has a P/E ratio of N/A, whereas GNNSF's P/E ratio is -16.94. In terms of profitability, QBIO's ROE is +0.44%, compared to GNNSF's ROE of -0.06%. Regarding short-term risk, QBIO is less volatile compared to GNNSF. This indicates potentially lower risk in terms of short-term price fluctuations for QBIO.
QBIO vs TKBIF Comparison
QBIO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QBIO stands at 14510.00. In comparison, TKBIF has a market cap of 2.79B. Regarding current trading prices, QBIO is priced at $0.00, while TKBIF trades at $23.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QBIO currently has a P/E ratio of N/A, whereas TKBIF's P/E ratio is 18.71. In terms of profitability, QBIO's ROE is +0.44%, compared to TKBIF's ROE of N/A. Regarding short-term risk, QBIO and TKBIF have similar daily volatility (0.00).
QBIO vs MPSYF Comparison
QBIO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QBIO stands at 14510.00. In comparison, MPSYF has a market cap of 2.76B. Regarding current trading prices, QBIO is priced at $0.00, while MPSYF trades at $73.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QBIO currently has a P/E ratio of N/A, whereas MPSYF's P/E ratio is -12.13. In terms of profitability, QBIO's ROE is +0.44%, compared to MPSYF's ROE of +7.43%. Regarding short-term risk, QBIO is less volatile compared to MPSYF. This indicates potentially lower risk in terms of short-term price fluctuations for QBIO.
QBIO vs ASPHF Comparison
QBIO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QBIO stands at 14510.00. In comparison, ASPHF has a market cap of 2.24B. Regarding current trading prices, QBIO is priced at $0.00, while ASPHF trades at $6.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QBIO currently has a P/E ratio of N/A, whereas ASPHF's P/E ratio is -35.83. In terms of profitability, QBIO's ROE is +0.44%, compared to ASPHF's ROE of -0.70%. Regarding short-term risk, QBIO and ASPHF have similar daily volatility (0.00).
QBIO vs BVNKF Comparison
QBIO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QBIO stands at 14510.00. In comparison, BVNKF has a market cap of 2.09B. Regarding current trading prices, QBIO is priced at $0.00, while BVNKF trades at $26.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QBIO currently has a P/E ratio of N/A, whereas BVNKF's P/E ratio is 10.63. In terms of profitability, QBIO's ROE is +0.44%, compared to BVNKF's ROE of +0.12%. Regarding short-term risk, QBIO is less volatile compared to BVNKF. This indicates potentially lower risk in terms of short-term price fluctuations for QBIO.
QBIO vs TRSBF Comparison
QBIO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QBIO stands at 14510.00. In comparison, TRSBF has a market cap of 1.95B. Regarding current trading prices, QBIO is priced at $0.00, while TRSBF trades at $0.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QBIO currently has a P/E ratio of N/A, whereas TRSBF's P/E ratio is 9.20. In terms of profitability, QBIO's ROE is +0.44%, compared to TRSBF's ROE of +0.11%. Regarding short-term risk, QBIO is less volatile compared to TRSBF. This indicates potentially lower risk in terms of short-term price fluctuations for QBIO.
QBIO vs BVNRY Comparison
QBIO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QBIO stands at 14510.00. In comparison, BVNRY has a market cap of 1.93B. Regarding current trading prices, QBIO is priced at $0.00, while BVNRY trades at $8.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QBIO currently has a P/E ratio of N/A, whereas BVNRY's P/E ratio is 9.81. In terms of profitability, QBIO's ROE is +0.44%, compared to BVNRY's ROE of +0.12%. Regarding short-term risk, QBIO is less volatile compared to BVNRY. This indicates potentially lower risk in terms of short-term price fluctuations for QBIO.
QBIO vs BTTAY Comparison
QBIO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QBIO stands at 14510.00. In comparison, BTTAY has a market cap of 1.92B. Regarding current trading prices, QBIO is priced at $0.00, while BTTAY trades at $24.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QBIO currently has a P/E ratio of N/A, whereas BTTAY's P/E ratio is -69.23. In terms of profitability, QBIO's ROE is +0.44%, compared to BTTAY's ROE of +0.05%. Regarding short-term risk, QBIO is less volatile compared to BTTAY. This indicates potentially lower risk in terms of short-term price fluctuations for QBIO.
QBIO vs MEOBF Comparison
QBIO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QBIO stands at 14510.00. In comparison, MEOBF has a market cap of 1.82B. Regarding current trading prices, QBIO is priced at $0.00, while MEOBF trades at $1.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QBIO currently has a P/E ratio of N/A, whereas MEOBF's P/E ratio is -15.89. In terms of profitability, QBIO's ROE is +0.44%, compared to MEOBF's ROE of -0.15%. Regarding short-term risk, QBIO is less volatile compared to MEOBF. This indicates potentially lower risk in terms of short-term price fluctuations for QBIO.
QBIO vs GENSF Comparison
QBIO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QBIO stands at 14510.00. In comparison, GENSF has a market cap of 1.78B. Regarding current trading prices, QBIO is priced at $0.00, while GENSF trades at $27.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QBIO currently has a P/E ratio of N/A, whereas GENSF's P/E ratio is -338.75. In terms of profitability, QBIO's ROE is +0.44%, compared to GENSF's ROE of +0.01%. Regarding short-term risk, QBIO is less volatile compared to GENSF. This indicates potentially lower risk in terms of short-term price fluctuations for QBIO.
QBIO vs PPTDF Comparison
QBIO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QBIO stands at 14510.00. In comparison, PPTDF has a market cap of 1.75B. Regarding current trading prices, QBIO is priced at $0.00, while PPTDF trades at $13.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QBIO currently has a P/E ratio of N/A, whereas PPTDF's P/E ratio is 17.57. In terms of profitability, QBIO's ROE is +0.44%, compared to PPTDF's ROE of +0.26%. Regarding short-term risk, QBIO is less volatile compared to PPTDF. This indicates potentially lower risk in terms of short-term price fluctuations for QBIO.
QBIO vs ONTTF Comparison
QBIO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QBIO stands at 14510.00. In comparison, ONTTF has a market cap of 1.63B. Regarding current trading prices, QBIO is priced at $0.00, while ONTTF trades at $1.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QBIO currently has a P/E ratio of N/A, whereas ONTTF's P/E ratio is -8.10. In terms of profitability, QBIO's ROE is +0.44%, compared to ONTTF's ROE of -0.27%. Regarding short-term risk, QBIO and ONTTF have similar daily volatility (0.00).
QBIO vs BRCTF Comparison
QBIO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QBIO stands at 14510.00. In comparison, BRCTF has a market cap of 1.62B. Regarding current trading prices, QBIO is priced at $0.00, while BRCTF trades at $18.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QBIO currently has a P/E ratio of N/A, whereas BRCTF's P/E ratio is -91.75. In terms of profitability, QBIO's ROE is +0.44%, compared to BRCTF's ROE of -0.19%. Regarding short-term risk, QBIO is less volatile compared to BRCTF. This indicates potentially lower risk in terms of short-term price fluctuations for QBIO.
QBIO vs BIESF Comparison
QBIO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QBIO stands at 14510.00. In comparison, BIESF has a market cap of 1.61B. Regarding current trading prices, QBIO is priced at $0.00, while BIESF trades at $32.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QBIO currently has a P/E ratio of N/A, whereas BIESF's P/E ratio is -45.71. In terms of profitability, QBIO's ROE is +0.44%, compared to BIESF's ROE of +0.05%. Regarding short-term risk, QBIO and BIESF have similar daily volatility (0.00).
QBIO vs GLPGF Comparison
QBIO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QBIO stands at 14510.00. In comparison, GLPGF has a market cap of 1.48B. Regarding current trading prices, QBIO is priced at $0.00, while GLPGF trades at $22.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QBIO currently has a P/E ratio of N/A, whereas GLPGF's P/E ratio is -7.34. In terms of profitability, QBIO's ROE is +0.44%, compared to GLPGF's ROE of -0.06%. Regarding short-term risk, QBIO is less volatile compared to GLPGF. This indicates potentially lower risk in terms of short-term price fluctuations for QBIO.
QBIO vs PHMMF Comparison
QBIO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QBIO stands at 14510.00. In comparison, PHMMF has a market cap of 1.42B. Regarding current trading prices, QBIO is priced at $0.00, while PHMMF trades at $80.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QBIO currently has a P/E ratio of N/A, whereas PHMMF's P/E ratio is 64.73. In terms of profitability, QBIO's ROE is +0.44%, compared to PHMMF's ROE of +0.10%. Regarding short-term risk, QBIO is less volatile compared to PHMMF. This indicates potentially lower risk in terms of short-term price fluctuations for QBIO.
QBIO vs CSBTF Comparison
QBIO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QBIO stands at 14510.00. In comparison, CSBTF has a market cap of 1.15B. Regarding current trading prices, QBIO is priced at $0.00, while CSBTF trades at $30.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QBIO currently has a P/E ratio of N/A, whereas CSBTF's P/E ratio is -250.00. In terms of profitability, QBIO's ROE is +0.44%, compared to CSBTF's ROE of -0.15%. Regarding short-term risk, QBIO and CSBTF have similar daily volatility (0.00).
QBIO vs NURPF Comparison
QBIO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QBIO stands at 14510.00. In comparison, NURPF has a market cap of 1.02B. Regarding current trading prices, QBIO is priced at $0.00, while NURPF trades at $8.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QBIO currently has a P/E ratio of N/A, whereas NURPF's P/E ratio is 11.63. In terms of profitability, QBIO's ROE is +0.44%, compared to NURPF's ROE of +0.49%. Regarding short-term risk, QBIO is less volatile compared to NURPF. This indicates potentially lower risk in terms of short-term price fluctuations for QBIO.
QBIO vs ASCLF Comparison
QBIO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QBIO stands at 14510.00. In comparison, ASCLF has a market cap of 821.88M. Regarding current trading prices, QBIO is priced at $0.00, while ASCLF trades at $0.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QBIO currently has a P/E ratio of N/A, whereas ASCLF's P/E ratio is -21.19. In terms of profitability, QBIO's ROE is +0.44%, compared to ASCLF's ROE of -0.09%. Regarding short-term risk, QBIO is less volatile compared to ASCLF. This indicates potentially lower risk in terms of short-term price fluctuations for QBIO.
QBIO vs CSPHF Comparison
QBIO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QBIO stands at 14510.00. In comparison, CSPHF has a market cap of 702.96M. Regarding current trading prices, QBIO is priced at $0.00, while CSPHF trades at $0.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QBIO currently has a P/E ratio of N/A, whereas CSPHF's P/E ratio is -51.80. In terms of profitability, QBIO's ROE is +0.44%, compared to CSPHF's ROE of -0.14%. Regarding short-term risk, QBIO is less volatile compared to CSPHF. This indicates potentially lower risk in terms of short-term price fluctuations for QBIO.
QBIO vs PHGUF Comparison
QBIO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QBIO stands at 14510.00. In comparison, PHGUF has a market cap of 621.12M. Regarding current trading prices, QBIO is priced at $0.00, while PHGUF trades at $0.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QBIO currently has a P/E ratio of N/A, whereas PHGUF's P/E ratio is -45.65. In terms of profitability, QBIO's ROE is +0.44%, compared to PHGUF's ROE of -0.06%. Regarding short-term risk, QBIO is less volatile compared to PHGUF. This indicates potentially lower risk in terms of short-term price fluctuations for QBIO.
QBIO vs BPMUF Comparison
QBIO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QBIO stands at 14510.00. In comparison, BPMUF has a market cap of 582.74M. Regarding current trading prices, QBIO is priced at $0.00, while BPMUF trades at $47.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QBIO currently has a P/E ratio of N/A, whereas BPMUF's P/E ratio is 6.88. In terms of profitability, QBIO's ROE is +0.44%, compared to BPMUF's ROE of -0.01%. Regarding short-term risk, QBIO is less volatile compared to BPMUF. This indicates potentially lower risk in terms of short-term price fluctuations for QBIO.
QBIO vs INRLF Comparison
QBIO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QBIO stands at 14510.00. In comparison, INRLF has a market cap of 543.23M. Regarding current trading prices, QBIO is priced at $0.00, while INRLF trades at $3.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QBIO currently has a P/E ratio of N/A, whereas INRLF's P/E ratio is -5.16. In terms of profitability, QBIO's ROE is +0.44%, compared to INRLF's ROE of -0.43%. Regarding short-term risk, QBIO and INRLF have similar daily volatility (0.00).
QBIO vs SOLTF Comparison
QBIO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QBIO stands at 14510.00. In comparison, SOLTF has a market cap of 531.31M. Regarding current trading prices, QBIO is priced at $0.00, while SOLTF trades at $5.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QBIO currently has a P/E ratio of N/A, whereas SOLTF's P/E ratio is -34.76. In terms of profitability, QBIO's ROE is +0.44%, compared to SOLTF's ROE of -0.07%. Regarding short-term risk, QBIO is less volatile compared to SOLTF. This indicates potentially lower risk in terms of short-term price fluctuations for QBIO.
QBIO vs IVEVF Comparison
QBIO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QBIO stands at 14510.00. In comparison, IVEVF has a market cap of 505.87M. Regarding current trading prices, QBIO is priced at $0.00, while IVEVF trades at $3.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QBIO currently has a P/E ratio of N/A, whereas IVEVF's P/E ratio is -1.05. In terms of profitability, QBIO's ROE is +0.44%, compared to IVEVF's ROE of +1.67%. Regarding short-term risk, QBIO and IVEVF have similar daily volatility (0.00).
QBIO vs CLTEF Comparison
QBIO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QBIO stands at 14510.00. In comparison, CLTEF has a market cap of 504.72M. Regarding current trading prices, QBIO is priced at $0.00, while CLTEF trades at $7.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QBIO currently has a P/E ratio of N/A, whereas CLTEF's P/E ratio is -7.06. In terms of profitability, QBIO's ROE is +0.44%, compared to CLTEF's ROE of -0.61%. Regarding short-term risk, QBIO and CLTEF have similar daily volatility (0.00).
QBIO vs CYDY Comparison
QBIO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QBIO stands at 14510.00. In comparison, CYDY has a market cap of 480.06M. Regarding current trading prices, QBIO is priced at $0.00, while CYDY trades at $0.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QBIO currently has a P/E ratio of N/A, whereas CYDY's P/E ratio is -19.48. In terms of profitability, QBIO's ROE is +0.44%, compared to CYDY's ROE of +0.07%. Regarding short-term risk, QBIO is less volatile compared to CYDY. This indicates potentially lower risk in terms of short-term price fluctuations for QBIO.
QBIO vs VBIZF Comparison
QBIO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QBIO stands at 14510.00. In comparison, VBIZF has a market cap of 472.97M. Regarding current trading prices, QBIO is priced at $0.00, while VBIZF trades at $0.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QBIO currently has a P/E ratio of N/A, whereas VBIZF's P/E ratio is 22.70. In terms of profitability, QBIO's ROE is +0.44%, compared to VBIZF's ROE of -0.00%. Regarding short-term risk, QBIO and VBIZF have similar daily volatility (0.00).
QBIO vs SNBIF Comparison
QBIO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QBIO stands at 14510.00. In comparison, SNBIF has a market cap of 471.70M. Regarding current trading prices, QBIO is priced at $0.00, while SNBIF trades at $6.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QBIO currently has a P/E ratio of N/A, whereas SNBIF's P/E ratio is -22.59. In terms of profitability, QBIO's ROE is +0.44%, compared to SNBIF's ROE of -0.92%. Regarding short-term risk, QBIO is less volatile compared to SNBIF. This indicates potentially lower risk in terms of short-term price fluctuations for QBIO.
QBIO vs CKDXF Comparison
QBIO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QBIO stands at 14510.00. In comparison, CKDXF has a market cap of 470.61M. Regarding current trading prices, QBIO is priced at $0.00, while CKDXF trades at $0.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QBIO currently has a P/E ratio of N/A, whereas CKDXF's P/E ratio is -1.26. In terms of profitability, QBIO's ROE is +0.44%, compared to CKDXF's ROE of +2.04%. Regarding short-term risk, QBIO is less volatile compared to CKDXF. This indicates potentially lower risk in terms of short-term price fluctuations for QBIO.
QBIO vs AAVXF Comparison
QBIO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QBIO stands at 14510.00. In comparison, AAVXF has a market cap of 457.38M. Regarding current trading prices, QBIO is priced at $0.00, while AAVXF trades at $7.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QBIO currently has a P/E ratio of N/A, whereas AAVXF's P/E ratio is -2.30. In terms of profitability, QBIO's ROE is +0.44%, compared to AAVXF's ROE of -1.10%. Regarding short-term risk, QBIO and AAVXF have similar daily volatility (0.00).
QBIO vs TBGNF Comparison
QBIO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QBIO stands at 14510.00. In comparison, TBGNF has a market cap of 433.72M. Regarding current trading prices, QBIO is priced at $0.00, while TBGNF trades at $0.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QBIO currently has a P/E ratio of N/A, whereas TBGNF's P/E ratio is -0.25. In terms of profitability, QBIO's ROE is +0.44%, compared to TBGNF's ROE of N/A. Regarding short-term risk, QBIO and TBGNF have similar daily volatility (0.00).
QBIO vs BXPHF Comparison
QBIO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QBIO stands at 14510.00. In comparison, BXPHF has a market cap of 429.87M. Regarding current trading prices, QBIO is priced at $0.00, while BXPHF trades at $0.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QBIO currently has a P/E ratio of N/A, whereas BXPHF's P/E ratio is -22.00. In terms of profitability, QBIO's ROE is +0.44%, compared to BXPHF's ROE of -0.18%. Regarding short-term risk, QBIO is less volatile compared to BXPHF. This indicates potentially lower risk in terms of short-term price fluctuations for QBIO.
QBIO vs NWBO Comparison
QBIO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QBIO stands at 14510.00. In comparison, NWBO has a market cap of 415.17M. Regarding current trading prices, QBIO is priced at $0.00, while NWBO trades at $0.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QBIO currently has a P/E ratio of N/A, whereas NWBO's P/E ratio is -4.13. In terms of profitability, QBIO's ROE is +0.44%, compared to NWBO's ROE of +1.13%. Regarding short-term risk, QBIO is less volatile compared to NWBO. This indicates potentially lower risk in terms of short-term price fluctuations for QBIO.
QBIO vs HBMHF Comparison
QBIO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QBIO stands at 14510.00. In comparison, HBMHF has a market cap of 407.69M. Regarding current trading prices, QBIO is priced at $0.00, while HBMHF trades at $0.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QBIO currently has a P/E ratio of N/A, whereas HBMHF's P/E ratio is 16.07. In terms of profitability, QBIO's ROE is +0.44%, compared to HBMHF's ROE of +0.02%. Regarding short-term risk, QBIO and HBMHF have similar daily volatility (0.00).
QBIO vs PTCHF Comparison
QBIO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QBIO stands at 14510.00. In comparison, PTCHF has a market cap of 403.52M. Regarding current trading prices, QBIO is priced at $0.00, while PTCHF trades at $1.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QBIO currently has a P/E ratio of N/A, whereas PTCHF's P/E ratio is 8.00. In terms of profitability, QBIO's ROE is +0.44%, compared to PTCHF's ROE of -0.22%. Regarding short-term risk, QBIO is less volatile compared to PTCHF. This indicates potentially lower risk in terms of short-term price fluctuations for QBIO.
QBIO vs CLVLY Comparison
QBIO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QBIO stands at 14510.00. In comparison, CLVLY has a market cap of 350.87M. Regarding current trading prices, QBIO is priced at $0.00, while CLVLY trades at $7.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QBIO currently has a P/E ratio of N/A, whereas CLVLY's P/E ratio is 14.89. In terms of profitability, QBIO's ROE is +0.44%, compared to CLVLY's ROE of +0.19%. Regarding short-term risk, QBIO is less volatile compared to CLVLY. This indicates potentially lower risk in terms of short-term price fluctuations for QBIO.
QBIO vs CLVLF Comparison
QBIO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QBIO stands at 14510.00. In comparison, CLVLF has a market cap of 348.36M. Regarding current trading prices, QBIO is priced at $0.00, while CLVLF trades at $6.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QBIO currently has a P/E ratio of N/A, whereas CLVLF's P/E ratio is 14.18. In terms of profitability, QBIO's ROE is +0.44%, compared to CLVLF's ROE of +0.19%. Regarding short-term risk, QBIO and CLVLF have similar daily volatility (0.00).
QBIO vs PRRUF Comparison
QBIO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QBIO stands at 14510.00. In comparison, PRRUF has a market cap of 321.29M. Regarding current trading prices, QBIO is priced at $0.00, while PRRUF trades at $0.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QBIO currently has a P/E ratio of N/A, whereas PRRUF's P/E ratio is -11.00. In terms of profitability, QBIO's ROE is +0.44%, compared to PRRUF's ROE of -0.28%. Regarding short-term risk, QBIO is less volatile compared to PRRUF. This indicates potentially lower risk in terms of short-term price fluctuations for QBIO.
QBIO vs BOVNF Comparison
QBIO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QBIO stands at 14510.00. In comparison, BOVNF has a market cap of 309.28M. Regarding current trading prices, QBIO is priced at $0.00, while BOVNF trades at $4.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QBIO currently has a P/E ratio of N/A, whereas BOVNF's P/E ratio is -8.55. In terms of profitability, QBIO's ROE is +0.44%, compared to BOVNF's ROE of -0.50%. Regarding short-term risk, QBIO and BOVNF have similar daily volatility (0.00).
QBIO vs IDRSF Comparison
QBIO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QBIO stands at 14510.00. In comparison, IDRSF has a market cap of 305.70M. Regarding current trading prices, QBIO is priced at $0.00, while IDRSF trades at $1.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QBIO currently has a P/E ratio of N/A, whereas IDRSF's P/E ratio is -0.93. In terms of profitability, QBIO's ROE is +0.44%, compared to IDRSF's ROE of +0.24%. Regarding short-term risk, QBIO and IDRSF have similar daily volatility (0.00).
QBIO vs PBBIF Comparison
QBIO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QBIO stands at 14510.00. In comparison, PBBIF has a market cap of 286.93M. Regarding current trading prices, QBIO is priced at $0.00, while PBBIF trades at $24.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QBIO currently has a P/E ratio of N/A, whereas PBBIF's P/E ratio is 266.67. In terms of profitability, QBIO's ROE is +0.44%, compared to PBBIF's ROE of +0.01%. Regarding short-term risk, QBIO is less volatile compared to PBBIF. This indicates potentially lower risk in terms of short-term price fluctuations for QBIO.
QBIO vs NGENF Comparison
QBIO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QBIO stands at 14510.00. In comparison, NGENF has a market cap of 239.92M. Regarding current trading prices, QBIO is priced at $0.00, while NGENF trades at $3.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QBIO currently has a P/E ratio of N/A, whereas NGENF's P/E ratio is -12.83. In terms of profitability, QBIO's ROE is +0.44%, compared to NGENF's ROE of -2.23%. Regarding short-term risk, QBIO is less volatile compared to NGENF. This indicates potentially lower risk in terms of short-term price fluctuations for QBIO.
QBIO vs ORYZF Comparison
QBIO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QBIO stands at 14510.00. In comparison, ORYZF has a market cap of 234.86M. Regarding current trading prices, QBIO is priced at $0.00, while ORYZF trades at $3.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QBIO currently has a P/E ratio of N/A, whereas ORYZF's P/E ratio is -43.29. In terms of profitability, QBIO's ROE is +0.44%, compared to ORYZF's ROE of -0.05%. Regarding short-term risk, QBIO and ORYZF have similar daily volatility (0.00).
QBIO vs NWPHF Comparison
QBIO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QBIO stands at 14510.00. In comparison, NWPHF has a market cap of 231.22M. Regarding current trading prices, QBIO is priced at $0.00, while NWPHF trades at $12.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QBIO currently has a P/E ratio of N/A, whereas NWPHF's P/E ratio is N/A. In terms of profitability, QBIO's ROE is +0.44%, compared to NWPHF's ROE of N/A. Regarding short-term risk, QBIO and NWPHF have similar daily volatility (0.00).
QBIO vs MDCLF Comparison
QBIO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QBIO stands at 14510.00. In comparison, MDCLF has a market cap of 230.69M. Regarding current trading prices, QBIO is priced at $0.00, while MDCLF trades at $6.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QBIO currently has a P/E ratio of N/A, whereas MDCLF's P/E ratio is -5.21. In terms of profitability, QBIO's ROE is +0.44%, compared to MDCLF's ROE of +0.60%. Regarding short-term risk, QBIO is less volatile compared to MDCLF. This indicates potentially lower risk in terms of short-term price fluctuations for QBIO.
QBIO vs HLOSF Comparison
QBIO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QBIO stands at 14510.00. In comparison, HLOSF has a market cap of 228.29M. Regarding current trading prices, QBIO is priced at $0.00, while HLOSF trades at $2.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QBIO currently has a P/E ratio of N/A, whereas HLOSF's P/E ratio is -7.03. In terms of profitability, QBIO's ROE is +0.44%, compared to HLOSF's ROE of -1.30%. Regarding short-term risk, QBIO is less volatile compared to HLOSF. This indicates potentially lower risk in terms of short-term price fluctuations for QBIO.
QBIO vs SPHDF Comparison
QBIO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QBIO stands at 14510.00. In comparison, SPHDF has a market cap of 225.73M. Regarding current trading prices, QBIO is priced at $0.00, while SPHDF trades at $17.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QBIO currently has a P/E ratio of N/A, whereas SPHDF's P/E ratio is -4.01. In terms of profitability, QBIO's ROE is +0.44%, compared to SPHDF's ROE of +0.89%. Regarding short-term risk, QBIO is less volatile compared to SPHDF. This indicates potentially lower risk in terms of short-term price fluctuations for QBIO.
QBIO vs RAONF Comparison
QBIO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QBIO stands at 14510.00. In comparison, RAONF has a market cap of 211.95M. Regarding current trading prices, QBIO is priced at $0.00, while RAONF trades at $1.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QBIO currently has a P/E ratio of N/A, whereas RAONF's P/E ratio is -20.33. In terms of profitability, QBIO's ROE is +0.44%, compared to RAONF's ROE of -0.71%. Regarding short-term risk, QBIO is less volatile compared to RAONF. This indicates potentially lower risk in terms of short-term price fluctuations for QBIO.
QBIO vs FPHAF Comparison
QBIO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QBIO stands at 14510.00. In comparison, FPHAF has a market cap of 209.54M. Regarding current trading prices, QBIO is priced at $0.00, while FPHAF trades at $3.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QBIO currently has a P/E ratio of N/A, whereas FPHAF's P/E ratio is -7.50. In terms of profitability, QBIO's ROE is +0.44%, compared to FPHAF's ROE of N/A. Regarding short-term risk, QBIO and FPHAF have similar daily volatility (0.00).
QBIO vs VSBC Comparison
QBIO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QBIO stands at 14510.00. In comparison, VSBC has a market cap of 207.03M. Regarding current trading prices, QBIO is priced at $0.00, while VSBC trades at $1.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QBIO currently has a P/E ratio of N/A, whereas VSBC's P/E ratio is N/A. In terms of profitability, QBIO's ROE is +0.44%, compared to VSBC's ROE of +0.00%. Regarding short-term risk, QBIO and VSBC have similar daily volatility (0.00).
QBIO vs FGHQF Comparison
QBIO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QBIO stands at 14510.00. In comparison, FGHQF has a market cap of 205.61M. Regarding current trading prices, QBIO is priced at $0.00, while FGHQF trades at $0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QBIO currently has a P/E ratio of N/A, whereas FGHQF's P/E ratio is 10.10. In terms of profitability, QBIO's ROE is +0.44%, compared to FGHQF's ROE of +0.00%. Regarding short-term risk, QBIO is less volatile compared to FGHQF. This indicates potentially lower risk in terms of short-term price fluctuations for QBIO.
QBIO vs HNSBF Comparison
QBIO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QBIO stands at 14510.00. In comparison, HNSBF has a market cap of 203.44M. Regarding current trading prices, QBIO is priced at $0.00, while HNSBF trades at $3.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QBIO currently has a P/E ratio of N/A, whereas HNSBF's P/E ratio is -2.34. In terms of profitability, QBIO's ROE is +0.44%, compared to HNSBF's ROE of +1.43%. Regarding short-term risk, QBIO is less volatile compared to HNSBF. This indicates potentially lower risk in terms of short-term price fluctuations for QBIO.
QBIO vs BSEM Comparison
QBIO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QBIO stands at 14510.00. In comparison, BSEM has a market cap of 200.51M. Regarding current trading prices, QBIO is priced at $0.00, while BSEM trades at $12.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QBIO currently has a P/E ratio of N/A, whereas BSEM's P/E ratio is -21.53. In terms of profitability, QBIO's ROE is +0.44%, compared to BSEM's ROE of +1.50%. Regarding short-term risk, QBIO is less volatile compared to BSEM. This indicates potentially lower risk in terms of short-term price fluctuations for QBIO.
QBIO vs AVCTF Comparison
QBIO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QBIO stands at 14510.00. In comparison, AVCTF has a market cap of 199.39M. Regarding current trading prices, QBIO is priced at $0.00, while AVCTF trades at $0.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QBIO currently has a P/E ratio of N/A, whereas AVCTF's P/E ratio is -4.73. In terms of profitability, QBIO's ROE is +0.44%, compared to AVCTF's ROE of -1.24%. Regarding short-term risk, QBIO is less volatile compared to AVCTF. This indicates potentially lower risk in terms of short-term price fluctuations for QBIO.
QBIO vs GNFTF Comparison
QBIO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QBIO stands at 14510.00. In comparison, GNFTF has a market cap of 176.25M. Regarding current trading prices, QBIO is priced at $0.00, while GNFTF trades at $3.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QBIO currently has a P/E ratio of N/A, whereas GNFTF's P/E ratio is 8.85. In terms of profitability, QBIO's ROE is +0.44%, compared to GNFTF's ROE of +0.27%. Regarding short-term risk, QBIO is less volatile compared to GNFTF. This indicates potentially lower risk in terms of short-term price fluctuations for QBIO.
QBIO vs SCNLF Comparison
QBIO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QBIO stands at 14510.00. In comparison, SCNLF has a market cap of 176.05M. Regarding current trading prices, QBIO is priced at $0.00, while SCNLF trades at $0.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QBIO currently has a P/E ratio of N/A, whereas SCNLF's P/E ratio is -5.66. In terms of profitability, QBIO's ROE is +0.44%, compared to SCNLF's ROE of +2.45%. Regarding short-term risk, QBIO and SCNLF have similar daily volatility (0.00).
QBIO vs OPORF Comparison
QBIO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QBIO stands at 14510.00. In comparison, OPORF has a market cap of 164.88M. Regarding current trading prices, QBIO is priced at $0.00, while OPORF trades at $0.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QBIO currently has a P/E ratio of N/A, whereas OPORF's P/E ratio is 12.00. In terms of profitability, QBIO's ROE is +0.44%, compared to OPORF's ROE of +0.42%. Regarding short-term risk, QBIO is less volatile compared to OPORF. This indicates potentially lower risk in terms of short-term price fluctuations for QBIO.
QBIO vs MLLCF Comparison
QBIO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QBIO stands at 14510.00. In comparison, MLLCF has a market cap of 155.61M. Regarding current trading prices, QBIO is priced at $0.00, while MLLCF trades at $4.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QBIO currently has a P/E ratio of N/A, whereas MLLCF's P/E ratio is -2.24. In terms of profitability, QBIO's ROE is +0.44%, compared to MLLCF's ROE of -0.36%. Regarding short-term risk, QBIO is less volatile compared to MLLCF. This indicates potentially lower risk in terms of short-term price fluctuations for QBIO.
QBIO vs RECEF Comparison
QBIO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QBIO stands at 14510.00. In comparison, RECEF has a market cap of 149.84M. Regarding current trading prices, QBIO is priced at $0.00, while RECEF trades at $0.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QBIO currently has a P/E ratio of N/A, whereas RECEF's P/E ratio is -10.00. In terms of profitability, QBIO's ROE is +0.44%, compared to RECEF's ROE of +2.26%. Regarding short-term risk, QBIO is less volatile compared to RECEF. This indicates potentially lower risk in terms of short-term price fluctuations for QBIO.
QBIO vs BRIBF Comparison
QBIO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QBIO stands at 14510.00. In comparison, BRIBF has a market cap of 134.10M. Regarding current trading prices, QBIO is priced at $0.00, while BRIBF trades at $0.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QBIO currently has a P/E ratio of N/A, whereas BRIBF's P/E ratio is -1.83. In terms of profitability, QBIO's ROE is +0.44%, compared to BRIBF's ROE of -0.10%. Regarding short-term risk, QBIO and BRIBF have similar daily volatility (0.00).
QBIO vs IPHYF Comparison
QBIO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QBIO stands at 14510.00. In comparison, IPHYF has a market cap of 133.63M. Regarding current trading prices, QBIO is priced at $0.00, while IPHYF trades at $1.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QBIO currently has a P/E ratio of N/A, whereas IPHYF's P/E ratio is -2.13. In terms of profitability, QBIO's ROE is +0.44%, compared to IPHYF's ROE of -1.81%. Regarding short-term risk, QBIO is less volatile compared to IPHYF. This indicates potentially lower risk in terms of short-term price fluctuations for QBIO.
QBIO vs AAPGV Comparison
QBIO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QBIO stands at 14510.00. In comparison, AAPGV has a market cap of 127.31M. Regarding current trading prices, QBIO is priced at $0.00, while AAPGV trades at $17.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QBIO currently has a P/E ratio of N/A, whereas AAPGV's P/E ratio is N/A. In terms of profitability, QBIO's ROE is +0.44%, compared to AAPGV's ROE of N/A. Regarding short-term risk, QBIO is less volatile compared to AAPGV. This indicates potentially lower risk in terms of short-term price fluctuations for QBIO.
QBIO vs IUGNF Comparison
QBIO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QBIO stands at 14510.00. In comparison, IUGNF has a market cap of 126.94M. Regarding current trading prices, QBIO is priced at $0.00, while IUGNF trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QBIO currently has a P/E ratio of N/A, whereas IUGNF's P/E ratio is -1.70. In terms of profitability, QBIO's ROE is +0.44%, compared to IUGNF's ROE of -0.96%. Regarding short-term risk, QBIO is less volatile compared to IUGNF. This indicates potentially lower risk in terms of short-term price fluctuations for QBIO.
QBIO vs PRNAF Comparison
QBIO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QBIO stands at 14510.00. In comparison, PRNAF has a market cap of 126.87M. Regarding current trading prices, QBIO is priced at $0.00, while PRNAF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QBIO currently has a P/E ratio of N/A, whereas PRNAF's P/E ratio is -1.39. In terms of profitability, QBIO's ROE is +0.44%, compared to PRNAF's ROE of -1.77%. Regarding short-term risk, QBIO and PRNAF have similar daily volatility (0.00).
QBIO vs AMGXF Comparison
QBIO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QBIO stands at 14510.00. In comparison, AMGXF has a market cap of 121.79M. Regarding current trading prices, QBIO is priced at $0.00, while AMGXF trades at $0.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QBIO currently has a P/E ratio of N/A, whereas AMGXF's P/E ratio is -0.46. In terms of profitability, QBIO's ROE is +0.44%, compared to AMGXF's ROE of -0.24%. Regarding short-term risk, QBIO is less volatile compared to AMGXF. This indicates potentially lower risk in terms of short-term price fluctuations for QBIO.
QBIO vs PSTTF Comparison
QBIO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QBIO stands at 14510.00. In comparison, PSTTF has a market cap of 117.53M. Regarding current trading prices, QBIO is priced at $0.00, while PSTTF trades at $0.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QBIO currently has a P/E ratio of N/A, whereas PSTTF's P/E ratio is -29.00. In terms of profitability, QBIO's ROE is +0.44%, compared to PSTTF's ROE of N/A. Regarding short-term risk, QBIO and PSTTF have similar daily volatility (0.00).
QBIO vs EPRXF Comparison
QBIO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QBIO stands at 14510.00. In comparison, EPRXF has a market cap of 108.29M. Regarding current trading prices, QBIO is priced at $0.00, while EPRXF trades at $3.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QBIO currently has a P/E ratio of N/A, whereas EPRXF's P/E ratio is -2.69. In terms of profitability, QBIO's ROE is +0.44%, compared to EPRXF's ROE of -1.99%. Regarding short-term risk, QBIO is less volatile compared to EPRXF. This indicates potentially lower risk in terms of short-term price fluctuations for QBIO.
QBIO vs ADOIF Comparison
QBIO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QBIO stands at 14510.00. In comparison, ADOIF has a market cap of 103.66M. Regarding current trading prices, QBIO is priced at $0.00, while ADOIF trades at $8.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QBIO currently has a P/E ratio of N/A, whereas ADOIF's P/E ratio is -2.59. In terms of profitability, QBIO's ROE is +0.44%, compared to ADOIF's ROE of +6.08%. Regarding short-term risk, QBIO and ADOIF have similar daily volatility (0.00).
QBIO vs PBIGF Comparison
QBIO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QBIO stands at 14510.00. In comparison, PBIGF has a market cap of 100.04M. Regarding current trading prices, QBIO is priced at $0.00, while PBIGF trades at $0.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QBIO currently has a P/E ratio of N/A, whereas PBIGF's P/E ratio is -8.56. In terms of profitability, QBIO's ROE is +0.44%, compared to PBIGF's ROE of -2.16%. Regarding short-term risk, QBIO and PBIGF have similar daily volatility (0.00).
QBIO vs ADOCY Comparison
QBIO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QBIO stands at 14510.00. In comparison, ADOCY has a market cap of 98.20M. Regarding current trading prices, QBIO is priced at $0.00, while ADOCY trades at $11.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QBIO currently has a P/E ratio of N/A, whereas ADOCY's P/E ratio is -3.36. In terms of profitability, QBIO's ROE is +0.44%, compared to ADOCY's ROE of +1.73%. Regarding short-term risk, QBIO and ADOCY have similar daily volatility (0.00).
QBIO vs TRGNF Comparison
QBIO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QBIO stands at 14510.00. In comparison, TRGNF has a market cap of 92.35M. Regarding current trading prices, QBIO is priced at $0.00, while TRGNF trades at $0.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QBIO currently has a P/E ratio of N/A, whereas TRGNF's P/E ratio is -2.19. In terms of profitability, QBIO's ROE is +0.44%, compared to TRGNF's ROE of -3.14%. Regarding short-term risk, QBIO is less volatile compared to TRGNF. This indicates potentially lower risk in terms of short-term price fluctuations for QBIO.
QBIO vs CMVLF Comparison
QBIO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QBIO stands at 14510.00. In comparison, CMVLF has a market cap of 90.12M. Regarding current trading prices, QBIO is priced at $0.00, while CMVLF trades at $1.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QBIO currently has a P/E ratio of N/A, whereas CMVLF's P/E ratio is -3.05. In terms of profitability, QBIO's ROE is +0.44%, compared to CMVLF's ROE of -0.30%. Regarding short-term risk, QBIO is less volatile compared to CMVLF. This indicates potentially lower risk in terms of short-term price fluctuations for QBIO.
QBIO vs MCURF Comparison
QBIO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QBIO stands at 14510.00. In comparison, MCURF has a market cap of 86.53M. Regarding current trading prices, QBIO is priced at $0.00, while MCURF trades at $0.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QBIO currently has a P/E ratio of N/A, whereas MCURF's P/E ratio is -16.90. In terms of profitability, QBIO's ROE is +0.44%, compared to MCURF's ROE of -1.02%. Regarding short-term risk, QBIO is less volatile compared to MCURF. This indicates potentially lower risk in terms of short-term price fluctuations for QBIO.
QBIO vs ACHFF Comparison
QBIO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QBIO stands at 14510.00. In comparison, ACHFF has a market cap of 80.41M. Regarding current trading prices, QBIO is priced at $0.00, while ACHFF trades at $1.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QBIO currently has a P/E ratio of N/A, whereas ACHFF's P/E ratio is -30.50. In terms of profitability, QBIO's ROE is +0.44%, compared to ACHFF's ROE of +0.56%. Regarding short-term risk, QBIO is less volatile compared to ACHFF. This indicates potentially lower risk in terms of short-term price fluctuations for QBIO.
QBIO vs KNTPF Comparison
QBIO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QBIO stands at 14510.00. In comparison, KNTPF has a market cap of 77.03M. Regarding current trading prices, QBIO is priced at $0.00, while KNTPF trades at $0.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QBIO currently has a P/E ratio of N/A, whereas KNTPF's P/E ratio is -3.55. In terms of profitability, QBIO's ROE is +0.44%, compared to KNTPF's ROE of -4.62%. Regarding short-term risk, QBIO and KNTPF have similar daily volatility (0.00).
QBIO vs ETXPF Comparison
QBIO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, QBIO stands at 14510.00. In comparison, ETXPF has a market cap of 75.96M. Regarding current trading prices, QBIO is priced at $0.00, while ETXPF trades at $0.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
QBIO currently has a P/E ratio of N/A, whereas ETXPF's P/E ratio is -6.50. In terms of profitability, QBIO's ROE is +0.44%, compared to ETXPF's ROE of -0.36%. Regarding short-term risk, QBIO and ETXPF have similar daily volatility (0.00).